Literature DB >> 3113940

Importance of carbenicillin and gentamicin cross-resistant serotype 0:12 Pseudomonas aeruginosa in six Athens hospitals.

N J Legakis, N Koukoubanis, K Malliara, D Michalitsianos, J Papavassiliou.   

Abstract

One hundred and six clinical isolates of Pseudomonas aeruginosa, collected from various hospitals were typed with O-antisera and studied for their susceptibility to antibiotics and phages. Forty-four of 49 multiresistant isolates belonged to the O12 serogroup, a serogroup rarely found among strains of other resistance phenotypes. Eleven of the 45, O12 isolates were resistant to all phages, and 31 were sensitive only to phage 68. The latter pattern was encountered in nine of the 61 strains comprising the other O-serogroups.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3113940     DOI： 10.1007/bf02017618

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN： 0722-2211            Impact factor:   3.267


  11 in total

1.  Dissociation of surface properties and "intrinsic" resistance to beta lactams in Pseudomonas aeruginosa.

Authors:  D M Livermore; T L Pitt
Journal:  J Med Microbiol       Date:  1986-11       Impact factor: 2.472

Review 2.  Molecular basis of bacterial outer membrane permeability.

Authors:  H Nikaido; M Vaara
Journal:  Microbiol Rev       Date:  1985-03

3.  The specificity of agglutination reactions of Pseudomonas aeruginosa with O antisera.

Authors:  T L Pitt; Y J Erdman
Journal:  J Med Microbiol       Date:  1978-02       Impact factor: 2.472

4.  Serotypes of Pseudomonas aeruginosa in clinical specimens in relation to antibiotic susceptibility.

Authors:  N J Legakis; M Aliferopoulou; J Papavassiliou; M Papapetropoulou
Journal:  J Clin Microbiol       Date:  1982-09       Impact factor: 5.948

5.  Cross-resistance of clinical isolates of Pseudomonas aeruginosa to five aminoglycosides.

Authors:  N J Legakis; J Tselentis; K J Courtis; J Papavassiliou
Journal:  J Antimicrob Chemother       Date:  1979-07       Impact factor: 5.790

6.  Resistance of Pseudomonas aeruginosa PAO to nalidixic acid and low levels of beta-lactam antibiotics: mapping of chromosomal genes.

Authors:  M Rella; D Haas
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

Review 7.  Epidemiology of infections due to Pseudomonas aeruginosa.

Authors:  A J Morrison; R P Wenzel
Journal:  Rev Infect Dis       Date:  1984 Sep-Oct

8.  Pseudomonas aeruginosa: evidence for the involvement of lipopolysaccharide in determining outer membrane permeability to carbenicillin and gentamicin.

Authors:  B G Shearer; N J Legakis
Journal:  J Infect Dis       Date:  1985-08       Impact factor: 5.226

9.  The effect of lipopolysaccharide composition on the ultrastructure of Pseudomonas aeruginosa.

Authors:  M Salkinoja-Salonen; E L Nurmiaho
Journal:  J Gen Microbiol       Date:  1978-03

10.  PSE-4 beta lactamase: a serotype-specific enzyme in Pseudomonas aeruginosa.

Authors:  D M Livermore; T L Pitt; C S Jones; J A Crees-Morris; R J Williams
Journal:  J Med Microbiol       Date:  1985-02       Impact factor: 2.472
View more
  10 in total

1.  Outer membrane alterations in multiresistant mutants of Pseudomonas aeruginosa selected by ciprofloxacin.

Authors:  N J Legakis; L S Tzouvelekis; A Makris; H Kotsifaki
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

2.  Virulence determinants in Pseudomonas aeruginosa strains from urinary tract infections.

Authors:  P Visca; F Chiarini; A Mansi; C Vetriani; L Serino; N Orsi
Journal:  Epidemiol Infect       Date:  1992-04       Impact factor: 2.451

3.  Emergence of multidrug resistance in ubiquitous and dominant Pseudomonas aeruginosa serogroup O:11. The Greek Pseudomonas Aeruginosa Study Group.

Authors:  P T Tassios; V Gennimata; A N Maniatis; C Fock; N J Legakis
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

4.  Outbreaks of multidrug-resistant Pseudomonas aeruginosa in community hospitals in Japan.

Authors:  Jun-Ichiro Sekiguchi; Tsukasa Asagi; Tohru Miyoshi-Akiyama; Atsushi Kasai; Yukie Mizuguchi; Minako Araake; Tomoko Fujino; Hideko Kikuchi; Satoru Sasaki; Hajime Watari; Tadashi Kojima; Hiroshi Miki; Keiji Kanemitsu; Hiroyuki Kunishima; Yoshihiro Kikuchi; Mitsuo Kaku; Hiroshi Yoshikura; Tadatoshi Kuratsuji; Teruo Kirikae
Journal:  J Clin Microbiol       Date:  2006-11-22       Impact factor: 5.948

5.  Epidemiology of community-acquired Pseudomonas aeruginosa infections in children.

Authors:  I Paraskaki; E Lebessi; N J Legakis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-10       Impact factor: 3.267

6.  Multiresistant serotype O 12 Pseudomonas aeruginosa: evidence for a common strain in Europe.

Authors:  T L Pitt; D M Livermore; D Pitcher; A C Vatopoulos; N J Legakis
Journal:  Epidemiol Infect       Date:  1989-12       Impact factor: 2.451

7.  Diversity of aminoglycoside resistance in Enterobacter cloacae in Greece.

Authors:  A C Vatopoulos; A Tsakris; L S Tzouvelekis; N J Legakis; T L Pitt; G H Miller; K J Shaw; M Antreou; M Nikolopoulou; Z Komninou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-02       Impact factor: 3.267

8.  Diversity of resistance phenotypes and plasmid analysis in multi-resistant 0:12 Pseudomonas aeruginosa.

Authors:  A Tsakris; A C Vatopoulos; L S Tzouvelekis; N J Legakis
Journal:  Eur J Epidemiol       Date:  1992-11       Impact factor: 8.082

Review 9.  Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data.

Authors:  Theodoros Karampatakis; Charalampos Antachopoulos; Athanassios Tsakris; Emmanuel Roilides
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-04-11       Impact factor: 3.267

10.  Pseudomonas aeruginosa population structure revisited.

Authors:  Jean-Paul Pirnay; Florence Bilocq; Bruno Pot; Pierre Cornelis; Martin Zizi; Johan Van Eldere; Pieter Deschaght; Mario Vaneechoutte; Serge Jennes; Tyrone Pitt; Daniel De Vos
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.